Synaptogenix, Inc.
Pharmaceutical company · New York, United States
Synaptogenix, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2012. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2.7 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2025.
Synaptogenix at a glance
What does Synaptogenix do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2.7 million in total (2019). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $5.5 million sold (2025).
Frequently asked questions about Synaptogenix
Where is Synaptogenix headquartered?
Synaptogenix, Inc. is headquartered in New York, United States.
What does Synaptogenix do?
Synaptogenix, Inc. is a pharmaceutical company.
When was Synaptogenix founded?
The earliest incorporation on record for Synaptogenix, Inc. is in 2012, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences